Is Oruka Therapeutics financially healthy?
Yes
Oruka Therapeutics could pay off all its debt with 0.4 years of earnings.
The numbers behind it
Net debt / EBITDA0.4 years
Cash vs. debt$47M vs. $2M
Current ratio23.8×Short-term assets for each $1 of bills due within a year
How we decide
We measure debt in years of earnings (net debt / EBITDA): under 1 is very comfortable, 1 to 3 is manageable, above 3 is heavy. A company that earns less than 3 times its interest bill also counts as weak.
More questions about Oruka Therapeutics
Data as of Nov 13, 2026.